CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)1 - USD ($)	6 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)1
Net Loss	$ (18,606,098)	$ (19,217,984)
Net Cash Used In Operating Activities:
Depreciation And Amortization	1,867,192	1,101,477
Share-based Payments For Services	402,270	552,664
Equity Based Compensation	6,655,002	6,579,051
Common Stock Contributed To 401(k) Plan	110,072	93,091
Gain On Short-term Investments	(615)	(5,728)
Loss On Patent Impairment	30,793	0
(Gain)/loss on derivative instruments	366,791	2,108,181
Modification Of Warrants	0	192
(increase)/decrease In Assets:
Receivables	54,922	0
Prepaid Expenses	2,552	680,490
Supplies Used For R&d And Manufacturing	1,288	638,771
Deposits	1,910,917	48,210
Increase/(decrease) In Liabilities:
Accounts Payable	46,033	123,920
Accrued Expenses	89,149	(142,744)
Due To Employees	222,112	9,083
Other Liabilities	43,594	20,793
Net Cash Used In Operating Activities	(7,537,608)	(8,784,495)
Cash Flows From Investing Activities:
Proceeds From Maturity (purchases) Of Us Treasury Bills	(6,152,000)	(11,145,667)
Purchases Of Property And Equipment	(550,861)	(6,629,050)
Expenditures For Patent Costs	(22,741)	0
Net Cash Provided By (used In) Investing Activities	5,578,398	(17,774,717)
Cash Flows From Financing Activities:
Proceeds From Issuance Of Common Stock	0	(13,559,500)
Payments Of Stock Issuance Costs	45,965	195,295
Proceeds From Exercises Of Warrants And Options	131,060	4,599,205
Proceeds From Landlord Funding Of Leasehold Improvements	786,454	0
Payments On Obligations Under Finance Lease	689,615	481,773
Net Cash Provided By Financing Activities	181,934	17,481,637
Net Decrease In Cash And Cash Equivalents	(1,777,276)	(9,077,575)
Cash And Cash Equivalents, Beginning Of Period	36,060,148	15,508,909
Cash And Cash Equivalents, End Of Period	$ 34,282,872	$ 6,431,334